Adenovirus-mediated gene transfer: Strategies and applications in lipoprotein research

Current Opinion in Lipidology

Volumn 7, Issue 2, 1996, Pages 105-111

  Gerard, Robert D ^a   Chan, Lawrence ^b,c  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c EAST TEXAS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS VECTOR;

ADENOVIRUS; CYTOTOXIC T LYMPHOCYTE; GENE EXPRESSION; GENE THERAPY; GENE TRANSFER; GENETIC TRANSCRIPTION; HUMAN; LIPOPROTEIN METABOLISM; LIVER; MEDICAL RESEARCH; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIRUS GENOME; VIRUS MORPHOLOGY;

ADENOVIRIDAE; MAMMALIA;

EID: 0029973447     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-199604000-00010     Document Type: Review

References (37)

1. Henry LJ, Xia D, Wilke M, Deisenhofer J, Gerard RD: Characterization of the knob domain of the adenovirus 5 fiber protein expressed in E. coli. J Virol 1994, 68:5239-5246.
2. 5 promote adenovirus internalization but not virus attachment Cell 1993, 73:309-319.
3. Graham FL, Prevec L: Manipulation of adenovirus vectors. In Methods in molecular biology vol 7: gene transfer and expression of protocols. Edited by Murray EJ. Clifton, New Jersey: Humana Press; 1991.
4. Gluzman Y, Reichl H, Solnick D: Helper free adenovirus type 5 vectors. In Eukaryotic viral vectors. Edited by Gluzman Y. New York: Cold Spring Harbor Laboratory; 1982:187-192.
5. McGrory WJ, Bautista DS, Graham FL: A simple technique for the rescue of early region 1 mutations into infectious human adenovirus type 5. Virology 1988, 163:614-617.
6. Gerard RD, Meidell RS: Adenovirus vectors. In DNA cloning: a practical approach: mammalian systems. Edited by Hames BD, Glover D. Oxford: Oxford University Press; 1995. A complete practical guide to the construction of adenovirus vectors.
7. Graham FL, Smiley J, Russell WC, Nairn R: Characteristics of a human cell line transformed by human adenovirus type 5. J Gen Virol 1977, 36: 59-72.
8. Berkner KL: Development of adenovirus vectors for the expression of heterologous genes. Bio Techniques 1988, 6:616-629.
9. Gerard RD, Meidell RS: Adenovirus-mediated gene transfer. Trends Cardiovasc Med 1993, 3:171-177.
10. Herz J, Gerard RD: Adenovirus-mediated low density lipoprotein receptor gene transfer accelerates cholesterol clearance in normal mice. Proc Natl Acad Sci USA 1993, 90:2812-2816.
11. Chan L: Use of somatic gene transfer to study lipoprotein metabolism in experimental animals in vivo. Curr Opin Lipidol 1995, 6:335-340. A review on the use of adenovirus-mediated gene transfer in lipoprotein research. The lipoprotein aspects of somatic gene transfer are emphasized.
12. Willnow TE, Sheng Z, Ishibashi S, Herz J: Inhibition of hepatic chylomicron remnant uptake by gene transfer of a receptor antagonist Science 1994, 264:1471-1474.
13. Chowdhury JR, Grossman M, Gupta S, Chowdhury NR, Baker TR Jr, Wilson JM: Long-term improvement of hypercholesterolemia after ex vivo gene therapy in LDLR-deficient rabbits. Science 1991, 254:1802-1805.
14. Ishibashi S, Brown MS, Goldstein JL, Gerard RD, Hammer RE, Herz J: Hypercholesterolemia in LDL receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J Clin Invest 1993, 92:883-893.
15. Kozarsky KF, McKinley DR, Austin LL, Raper SE, Stratford-Perricaudet LD, Wilson JM: In-vivo correction of low density lipoprotein receptor deficiency in the Watanabe heritable hyperlipidemic rabbit with recombinant adenovirus. J Biol Chem 1994, 269:13695-13702.
16. Li J, Fang B, Eisensmith RC, Li XHC, Nasonkin I, Lin-Lee Y-C, Mims MP, Hughes A, Montgomery CD, Roberts JD et al.: In-vivo gene therapy for hyperlipidemia: phenotypic correction in Watanabe rabbits by hepatic delivery of the rabbit LDL receptor gene. J Clin Invest 1995, 95:768-773. The authors of this article demonstrate the feasibility of adenovirus-mediated transfer of the LDL receptor gene in lowering plasma cholesterol in Watanabe rabbits.
17. Grossman M, Rader DJ, Muller DWM, Kolansky DM, Kozarsky K, Clark III BJ, Stein EA, Lupien PJ, Brewer HB Jr, Raper SE, Wilson JM: A pilot study of ex-vivo gene therapy for homozygous familial hypercholesterolaemia. Nature Med 1995, 1:1148-1154. This is the first report on ex-vivo gene therapy in five patients with familial hypercholesterolemia. Metabolic responses were quite variable. This study indicates that limited numbers of retrovirus-transduced hepatocytes were engrafted without significant morbidity.
18. Spady DK, Cuthbert JA, Willard MN, Meidell RS: Adenovirus-mediated transfer of a gene encoding cholesterol 7α-hydroxylase into hamsters increases hepatic enzyme activity and reduces plasma total and low density lipoprotein cholesterol. J Clin Invest 1995, 96:700-709. The effects of adenovirus-mediated transfer of cholesterol 7α-hydroxylase in hamsters in vivo were examined.
19. Stevenson SC, Marshall-Neff J, Teng B, Lee CB, Roy S, McClelland A: Phenotypic correction of hypercholesterolemia in apoE-deficient mice by adenovirus-mediated in-vivo gene transfer. Arterioscler Thromb 1995, 15:479-484. The authors examined the effect of apoE gene transfer on plasma cholesterol in apoE knockout mice.
20. Kashyap VS, Santamarina-Fojo S, Brown DR, Parrott CL, Applebaum-Bowden D, Meyn S, Talley G, Paigen B, Maeda N, Brewer HB Jr: Apolipoprotein E deficiency in mice: gene replacement and prevention of atherosclerosis using adenovirus vectors. J Clin Invest 1995, 96: 1612-1620. As well as examining the effect of apoE gene transfer on plasma cholesterol in apoE knockout mice, the authors also demonstrated that aortic atherosclerosis was slowed down in treated animals.
21. 100 and LDL production by adenovirus-mediated transfer of the APOBEC-1 gene in mice.
22. •] demonstrating the lowering of lipoprotein (a) in transgenic mice and induction of apoB messenger RNA editing in rabbits after adenovirus-mediated transfer of the APOBEC-1 gene.
23. Kobayashi K, Oka K, Forte T, Ishida B, Teng B, Ishimura-Oka K, Nakamuta M, Chan, L: Reversal of hypercholesterolemia in low density lipoprotein receptor knockout mice by adenovirus-mediated gene transfer of the very low density lipoprotein receptor. J Biol Chem 1996, 271:6851-6860. The authors demonstrate that the VLDL receptor is an effective therapeutic gene in the treatment of hypercholesterolemia in LDL receptor knockout mice.
24. Kopfler WP, Willard M, Betz T, Willard JE, Gerard RD, Meidell RS: Adenovirus-mediated transfer of a gene encoding human apolipoprotein A-1 into normal mice increases circulating high-density lipoprotein cholesterol. Circulation 1994, 90:1319-1327. The authors document the production of high levels of plasma apoA-I after gene transfer in mice in vivo.
25. Yang Y, Nunes FA, Berencsi K, Furth EE, Gönczöl E, Wilson JM: Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci USA 1994, 91:4407-4411.
26. + cytolylic lymphocytes as the primary immune effectors for hepatocyte destruction.
27. Barr D, Tubb J, Ferguson D, Scaria A, Lieber A, Wilson C, Perkins J, Wilson, Kay MA: Strain related variations in adenovirally-mediated transgene expression from house hepatocytes in vivo: comparisons between immunocompetent and immunodeficient inbred strains. Gene Therapy 1995, 2:151-155.
28. van Doren K, Gluzman Y: Efficient transformation of human fibroblasts by adenovirus-simian virus 40 recombinants. Mol Cell Biol 1984, 4: 1653-1656.
29. van Doren K, Hanahan D, Gluzman Y: Infection of eucaryotic cells by helper-independent recombinant adenoviruses: early region 1 is not obligatory for integration of viral DNA. J Virol 1984, 50:606-614.
30. Stratford-Perricaudet LD, Makeh I, Perricaudet M, Briand P: Widespread long-term gene transfer to mouse skeletal muscles and heart. J Clin Invest 1992, 90:626-630.
31. Weinberg DH, Ketner G: A cell line that supports the growth of a defective early region 4 deletion mutant human adenovirus type 2. Proc Natl Acad Sci USA 1983, 80:5383-5386.
32. Armentano D, Sookdeo CC, Hehir KM, Gregory RJ, St George JA, Prince GA, Wadsworth SC, Smith AE: Characterization of an adenovirus gene transfer vector containing an E4 deletion. Hum Gen Ther 1995, 6:1343-1353. An E4 deletion variant vector was characterized in this paper.
33. Mitani K, Graham FL, Caskey CT, Kochanek S: Rescue, propagation, and partial purification of a helper virus-dependent adenovirus vector. Proc Natl Acad Sci USA 1995, 92:3854-3858. The authors demonstrated the feasibility of rescuing and propagating a defective adenoviral genome with a gene of interest in the presence of a helper virus.
34. Engelhardt JF, Ye X, Doranz B, Wilson JM: Ablation of E2a in recombinant adenoviruses improves transgene persistence and decreases inflammatory response in mouse liver. Proc Natl Acad Sci USA 1994, 91:6196-6200.
35. Lochmuller H, Petrof BJ, Allen C, Prescott S, Massie B, Karpati G: Immunosuppression by FK506 markedly prolongs expression of adenovirus-delivered transgene in skeletal muscles of adult dystrophic [mdx] mice. Biochem Biophys Res Comm 1995, 213:569-574.
36. Kay MA, Holterman A-X, Meuse L, Gown A, Ochs HD, Linsley PS, Wilson CB: Long-term hepatic adenovirus-mediated expression in mice following CTLA4Ig administration. Nature Genet 1995, 11:191-197. The authors demonstrated a strategy that allows long-term transgene expression after adenovirus-mediated gene transfer by selected immunomodulation using CTLA4Ig administration.
37. Lee MG, Abina MA, Haddada H, Perricaudet M: The constitutive expression of the immunomodulatory gp 19k protein in E1, E3 adenoviral vectors strongly reduces the host cytolytic T cell response against the vector. Gene Ther 1995, 2:256-262.